Decrease in phosphorylation of ERK following decreased expression of NK cell-activating receptors in human NK cell line exposed to asbestos

International Journal of Immunopathology and Pharmacology

Volumn 22, Issue 4, 2009, Pages 879-888

  Nishimura, Yasumitsu ^a   Maeda, M ^a   Kumagai, N ^a   Hayashi, H ^a   Miura, Y ^b   Otsuki, T ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Asbestos; ERK; Natural killer cell; NK cell activating receptor

Indexed keywords

4 AMINO 7 TERT BUTYL 5 (4 CHLOROPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; 4 AMINO 7 TERT BUTYL 5 (4 METHYLPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; ANTIBODY; ASBESTOS; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NATURAL KILLER CELL RECEPTOR; NATURAL KILLER CELL RECEPTOR NKG2D; NATURAL KILLER CELL RECEPTOR NKG2D ANTIBODY; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG;

ARTICLE; CELL STRAIN K 562; CONTROLLED STUDY; CYTOTOXICITY; DEGRANULATION; ENZYME PHOSPHORYLATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LUNG CANCER; MESOTHELIOMA; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

EID: 76349089546     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463200902200403     Document Type: Article

References (23)

1. Sporn TA, Roggli VL. Mesothelioma. In Asbestos-Associated Diseases. V.L. Roggli, T.D. Oury, T.A. Sporn, ed. Springer-Verlag New York, 2004; p. 104-68.
2. Dusinska M, Collins A, Kazimirova A, et al. Genotoxic effects of asbestos in humans. Mutat Res 2004; 553:91-102.
3. Topinka J, Loli P, Georgiadis P, et al. Mutagenesis by asbestos in the lung of lambda-lacI transgenic rats. Mutat Res 2004; 553:67-78.
4. Miura Y, Nishimura Y, Katsuyama H, et al. Involvement of IL-10 and Bcl-2 in resistance against an asbestos-induced apoptosis of T cells. Apoptosis 2006; 11:1825-35.
5. Nishimura Y, Miura Y, Maeda M, et al. Expression of the T cell receptor Vbeta repertoire in a human T cell resistant to asbestos-induced apoptosis and peripheral blood T cells from patients with silica and asbestos-related diseases. Int J Immunopathol Pharmacol 2006; 19:795-805.
6. Nishimura Y, Miura Y, Maeda M, Kumagai N, Murakami S, Hayashi H, Fukuoka K, Nakano T, Otsuki T. Impairment in cytotoxicity and expression of NK cell-activating receptors on human NK cells caused by exposure to asbestos fibers. Int J Immunopathol Pharmacol 2009; 22:579-90.
7. Otsuki T, Maeda M, Murakami S, et al. Immunological effects of silica and asbestos. Cell Mol Immunol 2007; 4:261-8.
8. Moretta L, Moretta A. Unravelling natural killer cell function: triggering and inhibitory human NK receptors. EMBO J 2004; 23:255-9.
9. Yokoyama WM, Plougastel BF. Immune functions encoded by the natural killer gene complex. Nat Rev Immunol 2003; 3:304-16.
10. Moretta A, Bottino C, Vitale M, Pende D, Cantoni C, Mingari MC, Biassoni R, Moretta L. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu Rev Immunol 2001; 19:197-223.
11. Raulet DH. Roles of the NKG2D immunoreceptor and its ligands. Nat Rev Immunol 2003; 3:781-90.
12. Endt J, Eissmann P, Hoffmann SC, Meinke S, Giese T, Watzl C. Modulation of 2B4 (CD244) activity and regulated SAP expression in human NK cells. Eur J Immunol 2007; 37:193-8.
13. Garni-Wagner BA, Purohit A, Mathew PA, Bennett M, Kumar V. A novel function-associated molecule related to non-MHC-restricted cytotoxicity mediated by activated natural killer cells and T cells. J Immunol 1993; 151:60-70.
14. Valiante NM, Trinchieri G. Identification of a novel signal transduction surface molecule on human cytotoxic lymphocytes. J Exp Med 1993; 178:1397-406.
15. Sivori S, Pende D, Bottino C, Marcenaro E, Pessino A, Biassoni R, Moretta L, Moretta A. NKp46 is the major triggering receptor involved in the natural cytotoxicity of fresh or cultured human NK cells. Correlation between surface density of NKp46 and natural cytotoxicity against autologous; allogeneic or xenogeneic target cells. Eur J Immunol 1999; 29: 1656-66.
16. Chen X, Trivedi PP, Ge B, Krzewski K, Strominger JL. Many NK cell receptors activate ERK2 and JNKl to trigger microtubule organizing center and granule polarization and cytotoxicity. Proc Natl Acad Sci USA 2007; 104:6329-34.
17. Chen X, Allan DS, Krzewski K, Ge B, Kopcow H, Strominger JL. CD28-stimulated ERK2 phosphorylation is required for polarization of the microtubule organizing center and granules in YTS NK cells. Proc Natl Acad Sci USA 2006; 103:10346-51.
18. Winer BJ, Brown DR, Michels KM. Multifactor experiments having repeated measures on the same elements. In Statistical principles in experimental design. M.E. Chiappetta, J. Vaicunas, J.M. Morriss, ed. McGraw-Hill, Inc. New York, 1991; p. 497.
19. Nakajima H, Cella M, Langen H, Friedlein A, Colonna M. Activating interactions in human NK cell recognition: the role of 2B4-CD48. Eur J Immunol 1999; 29:1676-83.
20. O'Leary JG, Goodarzi M, Drayton DL, von Andrian UH. T cell- and B cell-independent adaptive immunity mediated by natural killer cells. Nat Immunol 2006; 7:507-16.
21. Lucas M, Schachterle W, Oberle K, Aichele P, Diefenbach A. Dendritic cells prime natural killer cells by trans-presenting interleukin 15. Immunity 2007; 26:503-17.
22. Barber MA, Zhang T, Gagne BA, Sentman CL. NK cells negatively regulate antigen presentation and tumor-specific CTLs in a syngeneic lymphoma model. J Immunol 2007; 178:6140-7.
23. Guan H, Moretto M, Bzik DJ, Gigley J, Khan IA. NK cells enhance dendritic cell response against parasite antigens via NKG2D pathway. J Immunol 2007; 179:590-6.